Published 3 days ago • loading... • Updated 3 days ago
Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET
Teva will release third-quarter 2026 results and host a conference call and webcast, with a replay available within 24 hours.
Teva Pharmaceutical Industries Ltd. announced yesterday that its Q3 2026 Aide Memoire is available on its website, providing investors information ahead of third quarter earnings.
With a history spanning over 120 years, Teva is transforming into a leading innovative biopharmaceutical company while maintaining its world-class generics business.
Following the earnings release on Tuesday, November 3, Teva will host a conference call and live webcast, with a replay available within 24 hours on its website.
The Pivot to Growth strategy aims to expand the innovative and biosimilar medicines pipeline while achieving expected cost savings through organizational transformation.
Under the Private Securities Litigation Reform Act, forward-looking statements involve substantial risks; marketplace competition and significant indebtedness could cause actual results to differ materially from expectations.